Comparable prognosis in different neonatal histidine-tryptophan-ketoglutarate dosage management

BACKGROUND: Histidine-tryptophan-ketoglutarate (HTK) is a solution commonly used for organ transplantation. However, there is no certified fixed regimen for on-pump heart surgery in neonates. We aimed to retrospectively evaluate the outcomes related to different HTK dosages and to analyze the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Li-Ting, Tong, Yuan-Yuan, Liu, Jin-Ping, Feng, Zheng-Yi, Zhao, Ju, Guo, Sheng-Wen, Jin, Yu, Zhang, Pei-Yao, Li, Yi-Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710314/
https://www.ncbi.nlm.nih.gov/pubmed/34711715
http://dx.doi.org/10.1097/CM9.0000000000001643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710314/
https://www.ncbi.nlm.nih.gov/pubmed/34711715
http://dx.doi.org/10.1097/CM9.0000000000001643

Ejemplares similares